Wall Street Signals: Featured Interview: CEO Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT)

Featured Interview: CEO Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT)


Chief Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT) comes back to Stock Day to give points of interest on Precision Oncology, tumor and medication testing, and developing by means of focused treatments. 


NASDAQ: AIPT # some time ago Skyline Medical: SKLN # FDA-endorsed STREAMWAY® System # Helomics Corporation # mechanized # bosom growth # Cytopatch # D-chip # FDA cleared # Lung malignancy # restorative gadgets # Ovarian disease # licensed # Precision Oncology # Tumor medicines # squander liquid administration